Tech5 months ago
Study: Anti-inflammatory drug celecoxib benefits PIK3CA-mutated colon cancer patients
An analysis of data from a randomized clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib, an...
